COOPERATION AGREEMENT
This Cooperation Agreement (this “Agreement”), dated as of January 31, 2024 is by and between (i) Hestia Capital Partners, LP and each of the persons set
forth on Exhibit A (collectively, “Hestia Capital”) and (ii) Pitney Bowes Inc. (the “Company”). Unless otherwise defined in this Agreement, capitalized terms shall have
the meanings given to them in Section 7. In consideration of and reliance upon the mutual covenants and agreements contained in this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which is hereby
acknowledged, Hestia Capital and the Company agree as follows:
1. Board Appointment and Nomination and Other Company Matters.
(a) The Company agrees that, immediately following the execution of this Agreement, the Board of Directors of the Company (the “Board”) and all
applicable committees thereof ii) will take all necessary actions to increase the size of the Board from eight (8) to ten (10) directors, and iii) will, following its review of William “Bill” Simon and Jill Sutton (each a “New Director” and together, the “New Directors”) in accordance with the Board’s internal procedures for the review of director candidates, take all
actions necessary to appoint each New Director as a Company director, effective as of February 1, 2024, with a term expiring at the Company’s 2024 annual meeting of stockholders (the “2024 Annual Meeting”); provided,
however, that as a condition to such appointment of each New Director, each New Director will have fully completed and executed the Company’s director candidate questionnaire (substantially in the form completed by the Company’s incumbent
non-management directors), and agreed to comply with all policies, procedures, codes, rules, standards, guidelines and confidentiality obligations applicable to all of the Company’s directors (or any applicable subset thereof), to provide the
information regarding himself or herself that is required to be disclosed for candidates for directors and directors in a proxy statement and other periodic reports under the federal securities laws of the United States of America and/or applicable
New York Stock Exchange (“NYSE”) rules and regulations.
(b) The Company agrees that:
(i) at the 2024 Annual Meeting, the Board will nominate each New Director for election as a director of the Company (subject only to the approval of each New Director to
such nomination), together with, and for the same term as, the other persons included in the Company’s slate of nominees for election as directors of the Company at the 2024 Annual Meeting in accordance with this Section 1(b);
(ii) the Board will neither nominate nor recommend that the stockholders of the Company vote to elect any incumbent directors serving on the Board as of the date of this
Agreement other than Steve Brill, Sheila Stamps, Darrell Thomas, Katie A. May, Milena Alberti-Perez, Todd Everett, and Kurtis J. Wolf as directors of the Company at the 2024 Annual Meeting;
(iii) the Company will use its reasonable best efforts (which will include recommending stockholders vote for the New Directors and soliciting proxies in support of the
election of the New Directors) to obtain the election of the New Directors at the 2024 Annual Meeting in a manner no less rigorous than the efforts used by the Company to obtain the election of any other independent director (as determined under
the listing rules of NYSE) nominee nominated by the Board to serve as a director on the Board at the 2024 Annual Meeting;
(iv) the New Directors shall receive (A) the same benefits of director and officer insurance, and any indemnity and exculpation arrangements available generally to the
non-management directors on the Board, (B) compensation for his or her service as a director on the same basis as the compensation received by other non-management directors on the Board, and (C) such other benefits on the same basis as all other
non-management directors on the Board; and
(v) at the Company’s 2025 annual meeting of stockholders (the “2025 Annual Meeting”), the Board will re-nominate each New
Director and Mr. Wolf for election as a director of the Company (subject only to the approval of each New Director and Mr. Wolf to such re-nomination), together with, and for the same term as, the other persons included in the Company’s slate of
nominees for election as directors of the Company at the 2025 Annual Meeting, and the Company will use its reasonable best efforts (which will include recommending stockholders vote for the New Directors and Mr. Wolf, and soliciting proxies in
support of the election of New Directors and Mr. Wolf) to obtain the election of the New Directors and Mr. Wolf at the 2025 Annual Meeting in a manner no less rigorous than the efforts used by the Company to obtain the election of any other
independent director (as determined under the listing rules of NYSE) nominee nominated by the Board to serve as a director on the Board at the 2025 Annual Meeting.
(c) If any New Director is not appointed to the Board pursuant to Section 1(a) or following any appointment pursuant to Section 1(a) is unable or unwilling to serve as a
director and ceases to be a director, resigns as a director, is removed as a director, or for any other reason fails to serve or is not serving as a director at any time prior to the expiration of the Cooperation Period (as defined below, and such
failure to be appointed to, or serve on, the Board, a “Director Absence”), then Hestia Capital shall be entitled to propose, in consultation with the Company and as approved by the Board (such approval not to
be unreasonably withheld, conditioned or delayed), a substitute director candidate who has been interviewed, assessed, investigated and recommended by a nationally recognized independent recruiting firm selected by Hestia Capital and who (i)
qualifies as “independent” pursuant to NYSE listing standards, (ii) has the relevant financial and business experience to be a director of the Company, and (iii) is independent of Hestia Capital (for the avoidance of doubt, the nomination by Hestia
Capital of such person to serve on the board of any other company shall not, in and of itself, cause such person to fail to be deemed independent of Hestia Capital) (such substitute director candidate, a “Replacement
Director”), and the Board and all applicable committees thereof shall take such actions necessary to appoint the Replacement Director to serve as a director of the Company; provided; however, that if at any such time of a
Director Absence Hestia Capital fails to beneficially own (as determined under Rule 13d-3 promulgated under the Exchange Act (as defined below)) in the aggregate at least the Hestia Capital Minimum Ownership Amount, then any decision to replace
such New Director, and any process related to any such replacement, will be made by the Board in its sole discretion. Subject to NYSE rules and applicable law, upon a Replacement Director’s appointment to the Board, the Board and all applicable
committees of the Board shall take all necessary actions to appoint such Replacement Director to any applicable committee of the Board of which the replaced director was a member immediately prior to such director’s resignation or removal. Any
Replacement Director designated pursuant to this Section 1(c) replacing a New Director prior to the mailing of the Company’s definitive proxy statement for the 2024 Annual Meeting shall stand for election at the 2024 Annual Meeting
together with the other director nominees. Upon a Replacement Director’s appointment to the Board, such Replacement Director shall be deemed to be a New Director for all purposes under this Agreement.
2. Cooperation.
(a) Hestia Capital agrees that, during the Cooperation Period, neither it nor any of its agents, subsidiaries, Affiliates, Associates, successors, assigns, officers, key employees or
directors will encourage any other person to, in any way publicly criticize, disparage, call into disrepute or otherwise defame or slander the Company or the Company’s subsidiaries, Affiliates, Associates, successors, assigns, current or former
officers, current or former directors, current or former employees, stockholders, agents or representatives or any of the Company’s businesses, products or services, including, without limitation: (i) in any document or report filed with or
furnished to the Securities and Exchange Commission (the “SEC”) or any other governmental agency, (ii) in any press release or other publicly available format or ix) to any journalist or member of the media
(including, without limitation, in a television, radio, newspaper or magazine interview). Notwithstanding the foregoing, nothing in this Section 2(a) or elsewhere in this Agreement shall prohibit Hestia Capital from making any statement or
disclosure required under the federal securities laws or other applicable laws (including, without limitation, to comply with any subpoena or other legal process from any governmental or regulatory authority with competent jurisdiction over Hestia
Capital) or stock exchange regulations, or from responding to any public statements made by the Company of the nature described in this Section 2(a), if such statement by the Company was made in breach of this Agreement.
(b) The Company agrees that, during the Cooperation Period, neither it nor any of its agents, subsidiaries, Affiliates, Associates, successors, assigns, officers, key employees or
directors will, or will knowingly encourage any other person to, in any way publicly criticize, disparage, call into disrepute or otherwise defame or slander Hestia Capital or any of Hestia Capital’s subsidiaries, Affiliates, Associates,
successors, assigns, current or former officers, current or former directors, current or former employees, stockholders, agents or representatives, or any of Hestia Capital’s businesses, products or services, including, without limitation: (i) in
any document or report filed with or furnished to the SEC or any other governmental agency, (ii) in any press release or other publicly available format or (iii) to any journalist or member of the media (including, without limitation, in a
television, radio, newspaper or magazine interview). Notwithstanding the foregoing, nothing in this Section 2(b) or elsewhere in this Agreement shall prohibit the Company from making any statement or disclosure required under the federal
securities laws or other applicable laws (including, without limitation, to comply with any subpoena or other legal process from any governmental or regulatory authority with competent jurisdiction over the Company) or stock exchange regulations,
or from responding to any public statements made by Hestia Capital of the nature described in this Section 2(b), if such statement by Hestia Capital was made in breach of this Agreement.
(c) During the Cooperation Period, Hestia Capital will cause all shares of common stock, par value $1 per share, of the Company (the “Company Common Stock”)
beneficially owned, directly or indirectly, by it, or by any of its controlled Affiliates or Associates, or any other securities of the Company for which Hestia Capital, or any of its controlled Affiliates or Associates, has the right to vote,
directly or indirectly, to be present in person or by proxy for quorum purposes and to be voted at any meeting of stockholders or at any adjournments or postponements thereof, whether such meeting is held at a physical location or virtually by
means of remote communications, and to consent in connection with any action by consent in lieu of a meeting, in each case in accordance with the Board’s recommendations with respect to (i) the election, removal or replacement of any director and
(ii) any other proposal to be submitted to the stockholders of the Company by either the Company or any stockholder of the Company; provided, however, that Hestia Capital shall be permitted to vote in its sole discretion on any
proposal of the Company in respect of any Extraordinary Transaction; provided, further, that in the event Institutional Shareholder Services, Inc. (“ISS”) and Glass, Lewis & Co. LLC (“Glass Lewis”) publish a voting recommendation that differs from the Board’s recommendation with respect to any proposal (other than proposals related to director elections, removals or replacements, the
authorization of shares, or the issuance of equity in connection with employee compensation) submitted to stockholders during the Cooperation Period, Hestia Capital and its controlled Affiliates and Associates will be permitted to vote, or, if
applicable, deliver consents or consent revocations with respect to, any shares beneficially owned by Hestia Capital or its controlled Affiliates and Associates in accordance with such ISS and Glass Lewis recommendation.
(d) During the Cooperation Period, except as otherwise provided in this Agreement, Hestia Capital will not, and it will cause its respective controlled Affiliates and Associates to not,
directly or indirectly, without the prior written consent of the Company:
(i) acquire, seek or propose (publicly or otherwise) or agree to acquire (except by way of equity grants received as directors of the Company, stock dividends or other
distributions or offerings made available to holders of Company Common Stock generally on a pro rata basis or pursuant to an Extraordinary Transaction), beneficial ownership, directly or indirectly and acting alone or in concert, whether by
purchase, tender or exchange offer, through the acquisition of control of another person, by joining a partnership, limited partnership, syndicate or other group, or through swap or hedging transactions or otherwise, any securities of the Company,
any rights decoupled from the underlying securities of the Company, or any derivative securities, contracts or instruments in any way related to the price of shares of Company Common Stock that would result in Hestia Capital (collectively with its
controlled Affiliates and Associates) owning, controlling or otherwise having any beneficial ownership interest in or aggregate economic exposure to more than 9.9% of the shares of Company Common Stock outstanding at such time, including, without
limitation, through the exercise of, or acquisition of, derivative securities;
(ii) seek or propose (publicly or otherwise) to influence or control the management or policies of the Company (it being understood that Mr. Wolf’s actions or service as
a director of the Company shall not be deemed to be actions by Hestia Capital or its controlled Affiliates and Associates seeking or proposing to influence or control the management or policies of the Company);
(iii) (A) request (publicly or otherwise) a special meeting of the Company’s stockholders, (B) submit, participate in or be the proponent of, any stockholder proposal to
the Company, (C) seek representation on, or nominate any candidate to, the Board, or (D) seek (including, without limitation, pursuing or encouraging any “withhold” or similar campaign) the removal of any member of the Board;
(iv) make a request for any stockholder list or other Company books and records;
(v) make, engage in, or in any way knowingly participate in, directly or indirectly, any “solicitation” of proxies (as such terms are used in the proxy rules of the SEC,
including, without limitation, engagement by use of or in coordination with a universal proxy card, but without regard to the exclusion set forth in Rule 14A-1(1)(2)(iv) of the Exchange Act) or consents to vote, or seek to advise, encourage or
influence any person with respect to the voting of any securities of the Company or any securities convertible or exchangeable into or exercisable for any such securities for the election of individuals to the Board or to approve stockholder
proposals, or become a “participant” in any contested “solicitation” for the election of directors with respect to the Company (as such terms are defined or used under the Exchange Act) (other than a “solicitation” or acting as a “participant” in
support of all of the nominees of the Board at any stockholder meeting);
(vi) submit (publicly or otherwise) a proposal or request for, offer of (with or without conditions), or knowingly take any action in support of a proposal or request
for, or offer of, any tender offer, exchange offer, merger, amalgamation, acquisition, recapitalization, consolidation, sale or acquisition of material assets, liquidation, dissolution or other extraordinary transaction involving the Company or any
of its subsidiaries or joint ventures or any of their respective securities, any material change in the capitalization, stock repurchase programs and practices, capital allocation programs and practices or dividend policy of the Company, any other
material change in the Company’s business or corporate structure, any modifications to the Company’s Restated Certificate of Incorporation (as may be amended, corrected, or amended and restated from time to time) or the Company’s Amended and
Restated By-laws (as may be amended, corrected, or amended and restated from time to time), the delisting of a class of securities of the Company from any stock exchange or any action that would result in a class of securities of the Company to
become eligible for termination of registration pursuant to Section 12(g)(4) of the Exchange Act, or take any action which would, or would reasonably be expected to, require public disclosure regarding any of the types of matters set forth in this
clause (vi);
(vii) knowingly encourage, assist or enter into any discussions, negotiations, arrangements or understandings with any person not a party to this Agreement (a “Third Party”) with respect to any of the foregoing, or otherwise form, join, or knowingly encourage, influence, advise or in any way participate in any “group” (as such term is defined in Section 13(d)(3) of the
Exchange Act) with any person not a party to this Agreement (other than controlled Affiliates or Associates, so long as any such controlled Affiliate or Associate agrees to be subject to, and bound by, the terms and conditions of this Agreement
and, if required under the Exchange Act, files a Schedule 13D or an amendment thereof, as applicable, within two (2) business days after disclosing that Hestia Capital has formed a group with such controlled Affiliate or Associate) with respect to
any securities of the Company or otherwise in any manner agree, attempt, seek or propose to deposit any securities of the Company in any voting trust or similar arrangement, or subject any securities of the Company to any agreement or arrangement
with respect to the voting thereof (including, without limitation, by granting any proxy, consent or other authority to vote), except as expressly set forth in this Agreement;
(viii) sell, assign, or otherwise transfer or dispose of shares of Company Common Stock, or any rights decoupled from such shares, beneficially owned by them, to any
Third Party that, to Hestia Capital’s knowledge (after due inquiry, it being understood that such knowledge shall be deemed to exist with respect to any publicly available information, including, but not limited to, information in documents filed
with the SEC), would result in such Third Party, together with its Affiliates and Associates, owning, controlling or otherwise having any beneficial or other ownership interest of, in the aggregate, more than 4.9% of the shares of Company Common
Stock outstanding at such time or would increase the beneficial ownership interest of any Third Party who, collectively with its Affiliates and Associates, has a beneficial or other ownership interest of, in the aggregate, more than 4.9% of the
shares of Company Common Stock outstanding at such time, except for Schedule 13G filers that are mutual funds, pension funds, index funds or investment fund managers with no known history of activism or known plans to engage in activism;
(ix) make any public disclosure, announcement or statement regarding any intent, purpose, plan or proposal with respect to the Board, the Company, its management,
policies, strategy, operations, financial results or affairs or any of its securities or assets or this Agreement that is inconsistent with the provisions of this Agreement;
(x) institute, solicit, knowingly encourage, assist or join, as a party, any litigation, arbitration or other proceedings against or involving the Company or any of its
current or former directors or officers (including, without limitation, derivative or class actions), other than (A) an action to enforce the provisions of this Agreement instituted in accordance with and subject to Section 9, (B) making
counterclaims with respect to any proceeding initiated by, or on behalf of, the Company against Hestia Capital, or (C) responding to or complying with a validly issued legal process that neither Hestia Capital nor any of its Affiliates initiated,
encouraged or facilitated;
(xi) enter into any discussions, negotiations, understandings or agreements (whether written or oral) with, or advise, finance, assist, seek to persuade or knowingly
encourage, any Third Party to take any action or make any statement with respect to any of the foregoing, or advise, assist, knowingly encourage or seek to persuade any Third Party to take any action or make any statement with respect to any of the
foregoing, or otherwise take or cause any action or make any statement inconsistent with any of the foregoing; or
(xii) take any action that could reasonably be expected to force the Company to make a public disclosure with respect to any of the foregoing.
(e) Hestia Capital also agrees not to, and to cause its controlled Affiliates and Associates not to, request during the Cooperation Period that the Company (or its directors, officers,
employees or agents), directly or indirectly, amend or waive any provision of this Section 2 (including, without limitation, this sentence), publicly or in a manner that is intended to or would reasonably be expected to require public
disclosure of such request.
(f) The Company and Hestia Capital hereby covenant not to assert, commence or maintain or assist any Third Party in asserting, commencing or maintaining any claim, action or proceeding
before any court, agency or other governmental authority (including, without limitation, the SEC) alleging that any public filings, communications or soliciting materials made or delivered by the Company or Hestia Capital or their respective
Affiliates prior to the execution of this Agreement violates Rule 14a-9 under the Exchange Act, or contains any statement which, at the time and in light of the circumstances under which it was made, was false or misleading with respect to a
material fact, or omits to state a material fact necessary to make the statements contained therein not false or misleading.
(g) Notwithstanding anything set forth in this Agreement to the contrary, nothing in this Agreement shall prohibit or restrict Hestia Capital from (i) providing its views privately to the
Board or management on any matter or to privately request a waiver of any provision of this Agreement, provided that such actions are not intended to and would not reasonably be expected to require public disclosure of such actions, (ii) taking any
action to the extent reasonably necessary to comply with any law, rule or regulation or any action required by any governmental or regulatory authority or stock exchange that has jurisdiction over Hestia Capital or any of its Affiliates or
Associates or (iii) privately communicating to any of Hestia Capital’s potential investors or investors publicly available factual information regarding the Company consistent with prior practice in Hestia Capital’s annual and quarterly investor
letters.
(h) Nothing in this Agreement shall limit in any respect the actions of any director of the Company in his or her capacity as such, recognizing that such actions are subject to such
director’s fiduciary duties to the Company and its stockholders (it being understood and agreed that neither Hestia Capital nor any of its controlled Affiliates shall seek to do indirectly through any director or other party anything that would be
prohibited if done by Hestia Capital or its controlled Affiliates). Nothing in this Agreement shall prevent Hestia Capital from freely voting its shares of Company Common Stock (except as otherwise provided in Section 2 hereto) or taking
any actions as specifically contemplated in this Agreement.
3. Public Announcement.
(a) The Company will announce this Agreement and the material terms hereof by means of a press release in substantially the form attached to this Agreement as Exhibit B (the “Press Release”) promptly following the date of this Agreement.
(b) None of Hestia Capital, or any of its respective controlled Affiliates or Associates will issue a press release or make or cause to be made any other public statement or announcement
in connection with this Agreement or the actions contemplated hereby, other than as mutually agreed by the Company and Hestia Capital, except as set forth in Section 3(d) or as required by law or the rules of any stock exchange.
(c) The Company shall file with the SEC a Current Report on Form 8-K reporting its entry into this Agreement and appending this Agreement and the Press Release as exhibits thereto (the “Form 8-K”). The Form 8-K shall be consistent with the terms of this Agreement. The Company shall provide Hestia Capital with a reasonable opportunity to review and comment on the Form 8-K prior to the filing with
the SEC and consider in good faith any such comments of Hestia Capital.
(d) No later than two (2) business days following the date of this Agreement, Hestia Capital shall file with the SEC an amendment to that certain Schedule 13D, in compliance with Section
13 of the Exchange Act, to report its entry into this Agreement (the “Hestia Capital Schedule 13D Amendment”). The disclosures in the Hestia Capital 13D Amendment relating to this Agreement shall be
consistent with the terms of this Agreement. Hestia Capital shall provide the Company with a reasonable opportunity to review and comment on the Hestia Capital Schedule 13D Amendment prior to it being filed with the SEC and consider in good faith
any such comments of the Company.
4. Representations and Warranties of the Company. The Company represents and warrants to Hestia Capital as follows: (a) the Company has the power and authority to execute, deliver
and carry out the terms and provisions of this Agreement and to consummate the transactions contemplated by this Agreement, (b) this Agreement has been duly and validly authorized, executed and delivered by the Company, constitutes a valid and
binding obligation and agreement of the Company and is enforceable against the Company in accordance with its terms, except as enforcement of this Agreement may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent
conveyance or similar laws generally affecting the right of creditors and subject to general equity principles, and (c) the execution, delivery and performance of this Agreement by the Company does not and will not (i) require the approval of the
stockholders of the Company, (ii) violate or conflict with any law, rule, regulation, order, judgment or decree applicable to the Company, or (iii) result in any breach or violation of or constitute a default (or an event which with notice or lapse
of time or both would constitute such a breach, violation or default) under or pursuant to, or result in the loss of a material benefit under, or give any right of termination, amendment, acceleration or cancellation of, any organizational document
or material agreement to which the Company is a party or by which it is bound.
5. Representations and Warranties of Hestia Capital. Hestia Capital represents and warrants to the Company as follows: (a) each member of Hestia Capital has the power and authority
to execute, deliver and carry out the terms and provisions of this Agreement and to consummate the transactions contemplated by this Agreement, (b) this Agreement has been duly and validly authorized, executed and delivered by each member of Hestia
Capital, constitutes a valid and binding obligation and agreement of each member of Hestia Capital and is enforceable against each member of Hestia Capital in accordance with its terms, except as enforcement of this Agreement may be limited by
applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance or similar laws generally affecting the right of creditors and subject to general equity principles, (c) as of the date of this Agreement, Hestia Capital
beneficially owns 15,790,922 shares of the Company Common Stock in the aggregate which represents approximately 9.0% of the issued and outstanding shares of the Company Common Stock reported by the Company in its Quarterly Report on Form 10-Q,
dated as of November 2, 2023, (d) Hestia Capital is not and will not become party to any agreement, arrangement or understanding (whether written or oral) with any New Director with respect to such person’s service as a director on the Board, and
(e) the execution, delivery and performance of this Agreement by Hestia Capital does not and will not (i) violate or conflict with any law, rule, regulation, order, judgment or decree applicable to Hestia Capital, or (ii) result in any breach or
violation of or constitute a default (or an event which with notice or lapse of time or both would constitute such a breach, violation or default) under or pursuant to, or result in the loss of a material benefit under, or give any right of
termination, amendment, acceleration or cancellation of, any organizational document, agreement, contract, commitment, understanding or arrangement to which such member is a party or by which it is bound.
6. No Other Discussions or Arrangements. Hestia Capital represents and warrants that, as of the date of this Agreement, except as publicly disclosed in its SEC filings, in this
Agreement, or otherwise specifically disclosed to the Company in writing prior to the date of this Agreement, (a) Hestia Capital does not own, of record or beneficially, any Company Common Stock or any securities convertible into, or exchangeable
or exercisable for, any Company Common Stock and (b) Hestia Capital has not entered into, directly or indirectly, any agreements or understandings with any person with respect to any potential transaction involving the Company or the voting or
disposition of any securities of the Company.
7. Definitions. For purposes of this Agreement:
(a) the terms “Affiliate” and “Associate” have the respective meanings set forth in Rule 12b-2 promulgated by the SEC under the Securities Exchange Act of 1934, as amended, and with the
rules and regulations thereunder (the “Exchange Act”);
(b) the terms “beneficial owner” and “beneficially own” have the same meanings as set forth in Rule 13d-3 promulgated by the SEC under the Exchange Act;
(c) “Change of Control” shall be deemed to have taken place if (i) any person is or becomes a beneficial owner, directly or indirectly, of securities of the Company representing more than
fifty percent (50%) of the equity interests and voting power of the Company’s then-outstanding equity securities or (ii) the Company enters into a stock-for-stock transaction whereby immediately after the consummation of the transaction the
Company’s stockholders retain, directly or indirectly, less than fifty percent (50%) of the equity interests and voting power of the surviving entity’s then-outstanding equity securities;
(d) “Extraordinary Transaction” means any equity tender offer, equity exchange offer, merger, acquisition, joint venture, business combination, financing, recapitalization, reorganization,
restructuring, disposition, distribution, or other transaction with a Third Party that, in each case, would result in a Change of Control of the Company, liquidation, dissolution or other extraordinary transaction involving a majority of its equity
securities or a majority of its assets (determined on a consolidated basis), and, for the avoidance of doubt, including, without limitation, any such transaction with a Third Party that is submitted for a vote of the Company’s stockholders; and
(e) “Hestia Capital Minimum Ownership Amount” means the lesser of (i) 5.0% of the then outstanding shares of Company Common Stock and (ii) 8,816,562 shares of Company Common Stock (subject
to adjustment for stock splits, reclassifications, combinations and similar adjustments).
(f) The terms “person” or “persons” mean any individual, corporation (including, without limitation, not-for-profit), general or limited partnership, limited liability or unlimited
liability company, joint venture, estate, trust, association, organization or other entity of any kind, structure or nature.
8. Notices. All notices, consents, requests, instructions, approvals and other communications provided for in this Agreement and all legal process in regard to this Agreement will
be in writing and will be deemed validly given, made or served, if (a) given by email, when such email is sent to the email address set forth below and the appropriate confirmation of transmission is received or (b) if given by any other means,
when actually received during normal business hours at the address specified in this Section 8 (or to such other address that may be designated by a party from time to time in accordance with this Section 8):
if to the Company:
Pitney Bowes Inc.
3001 Summer Street
Stamford, CT 06926
Attention: Executive Vice President, Chief Legal Officer and Corporate Secretary
with a copy (which shall not constitute notice) to:
Vinson & Elkins L.L.P.
1114 Avenue of the Americas, 32nd Floor
New York, NY 10103
Attention: Lawrence S. Elbaum
C. Patrick Gadson
if to Hestia Capital:
Hestia Capital Partners, LP
175 Brickyard Road, Suite 200
Adams Township, PA 16046
Attention: Kurtis J. Wolf (kwolf@hestiacapital.com)
with a copy (which shall not constitute notice) to:
Olshan Frome Wolosky LLP
1325 Avenue of the Americas
New York, NY 10019
Attention: Andrew Freedman
Ian Engoron
9. Specific Performance; Remedies.
(a) The Company and Hestia Capital acknowledge and agree that irreparable injury to the other parties hereto would occur in the event any of the provisions of this Agreement were not
performed in accordance with their specific terms or were otherwise breached and that such injury would not be adequately compensable by the remedies available at law (including, without limitation, the payment of money damages). It is accordingly
agreed that, in furtherance and not in limitation of Section 9(b), the Company and Hestia Capital will be entitled to seek an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and
provisions of this Agreement, in addition to any other remedy to which they are entitled at law or in equity. FURTHERMORE, EACH OF THE COMPANY AND HESTIA CAPITAL (i) IRREVOCABLY WAIVES THE RIGHT TO TRIAL BY JURY AND (ii) AGREES TO WAIVE ANY BONDING
REQUIREMENT UNDER ANY APPLICABLE LAW, IN THE CASE ANY OTHER PARTY SEEKS TO ENFORCE THE TERMS BY WAY OF EQUITABLE RELIEF. THIS AGREEMENT WILL BE GOVERNED IN ALL RESPECTS, INCLUDING, WITHOUT LIMITATION, VALIDITY, INTERPRETATION AND EFFECT, BY THE
LAWS OF THE STATE OF DELAWARE WITHOUT GIVING EFFECT TO THE CHOICE OF LAW PRINCIPLES OF SUCH STATE.
(b) Notwithstanding any other Section in this Agreement and without limiting any other remedies the Company may have in law or equity, in the event that Hestia Capital (or any controlled
Affiliate or Associate of Hestia Capital) fails to perform or otherwise fulfill its obligations set forth in Section 2 in any material respect, and has not remedied such failure or non-fulfillment if capable of being remedied or fulfilled
within five (5) business days following written notice from the Company of such failure or non-fulfillment, the Company will not be required to perform or fulfill its obligations set forth in Section 1 or Section 2.
10. Severability. If at any time subsequent to the date hereof, any provision of this Agreement is held by any court of competent jurisdiction to be illegal, void or unenforceable,
such provision will be of no force and effect, but the illegality or unenforceability of such provision will have no effect upon the legality or enforceability of any other provision of this Agreement.
11. Term; Termination. The term of this Agreement will commence on the date of this Agreement and shall continue until the date that is thirty (30) days prior to the first day of
the advance notice period for the submission by stockholders of director nominations for consideration at the Company’s 2026 annual meeting of stockholders (the “2026 Annual Meeting”) (such period, the “Cooperation Period”); provided, however, that the Cooperation Period shall be extended until the date that is thirty (30) days prior to the first day of the advance notice period for the
submission by stockholders of director nominations for consideration at the Company’s 2027 annual meeting of stockholders if n) the Board agrees to re-nominate the New Directors for election at the 2026 Annual Meeting, o) the Board agrees to
re-nominate Mr. Wolf for election at the 2026 Annual Meeting and Mr. Wolf agrees to such re-nomination, and p) such re-nominations occur no later than forty (40) days prior to the first day of the advance notice period for submission by
stockholders of director nominations at the 2026 Annual Meeting; provided, further, that either party may terminate this Agreement if the other party commits a material breach of its obligations under this Agreement (that if capable
of being cured) is not cured within five (5) business days after the non-breaching party’s receipt of written notice specifying the material breach from the breaching party or, if impossible to cure within five (5) business days, which the
breaching party has not taken any substantive action to cure within such five (5) business day period. Notwithstanding the foregoing, the provisions of Section 11 through Section 16 shall survive the termination of this Agreement.
Termination of this Agreement shall not relieve any party from its responsibilities in respect of any breach of this Agreement prior to such termination.
12. Counterparts. This Agreement may be executed in one or more counterparts and by scanned computer image (such as pdf), each of which will be deemed to be an original copy of this
Agreement, but all of which together shall be deemed to be one and the same agreement.
13. No Third Party Beneficiaries. This Agreement is solely for the benefit of the Company and Hestia Capital and their respective permitted assignees and is not enforceable by any
other persons. No party to this Agreement may assign its rights or delegate its obligations under this Agreement, whether by operation of law or otherwise, and any assignment in contravention hereof will be null and void; provided, that
each party may assign any of its rights and delegate any of its obligations hereunder to any person that acquires substantially all of that party’s assets, whether by stock sale, merger, asset sale or otherwise.
14. No Waiver. No failure or delay by either party in exercising any right or remedy hereunder will operate as a waiver thereof, nor will any single or partial waiver thereof
preclude any other or further exercise thereof or the exercise of any other right or remedy hereunder.
15. Entire Understanding. This Agreement contains the entire understanding of the parties with respect to the subject matter hereof and supersedes any and all prior and
contemporaneous agreements, memoranda, arrangements and understandings, both written and oral, between the parties, or any of them, with respect to the subject matter of this Agreement. This Agreement may be amended only by an agreement in writing
executed by the Company and Hestia Capital.
16. Interpretation and Construction. Each of the Company and Hestia Capital acknowledges that it has been represented by counsel of its choice throughout all negotiations that have
preceded the execution of this Agreement, and that it has executed the same with the advice of said counsel. Each party and its counsel cooperated and participated in the drafting and preparation of this Agreement and the documents referred to in
this Agreement, and any and all drafts relating thereto exchanged among the parties will be deemed the work product of all of the parties and may not be construed against any party by reason of its drafting or preparation. Accordingly, any rule of
law or any legal decision that would require interpretation of any ambiguities in this Agreement against any party that drafted or prepared it is of no application and is hereby expressly waived by each of the Company and Hestia Capital, and any
controversy over interpretations of this Agreement will be decided without regard to events of drafting or preparation. In this Agreement, unless a clear contrary intention appears, (a) the word “including” (in its various forms) means “including,
without limitation;” (b) the words “hereunder,” “hereof,” “herein,” “hereto” and words of similar import are references in this Agreement as a whole and not to any particular provision of this Agreement; (c) the word “or” is not exclusive; (d)
references to “Sections” in this Agreement are references to Sections of this Agreement unless otherwise indicated; and (e) whenever the context requires, the masculine gender shall include the feminine and neuter genders.
[Signature page follows]
IN WITNESS WHEREOF, this Agreement has been duly executed and delivered by the duly
authorized signatories of the parties as of the date hereof.
| |
PITNEY BOWES INC.
|
| |
|
|
| |
By:
|
/s/ Jason C. Dies
|
| |
Name:
|
Jason C. Dies
|
| |
Title:
|
Interim Chief Executive Officer
|
| |
HESTIA CAPITAL PARTNERS, LP
|
| |
|
|
| |
By:
|
Hestia Capital Management, LLC,
|
| |
|
its Investment Manager
|
| |
|
|
| |
By:
|
/s/ Kurtis J. Wolf
|
| |
Name:
|
Kurtis J. Wolf
|
| |
Title:
|
Managing Member
|
| |
HELIOS I, LP
|
| |
|
|
| |
By:
|
Hestia Capital Management, LLC,
|
| |
|
its Investment Manager
|
| |
|
|
| |
By:
|
/s/ Kurtis J. Wolf
|
| |
Name:
|
Kurtis J. Wolf
|
| |
Title:
|
Managing Member
|
| |
HESTIA CAPITAL PARTNERS GP, LLC
|
| |
|
|
| |
By:
|
/s/ Kurtis J. Wolf
|
| |
Name:
|
Kurtis J. Wolf
|
| |
Title:
|
Managing Member
|
| |
HESTIA CAPITAL MANAGEMENT, LLC
|
| |
|
|
| |
By:
|
/s/ Kurtis J. Wolf
|
| |
Name:
|
Kurtis J. Wolf
|
| |
Title:
|
Managing Member
|
[Signature Page to Cooperation Agreement]
| |
KURTIS J. WOLF
|
| |
|
|
| |
By:
|
/s/ Kurtis J. Wolf
|
| |
Name:
|
Kurtis J. Wolf
|
[Signature Page to Cooperation Agreement]
EXHIBIT A
Hestia Capital Affiliates
1. Helios I, LP
2. Hestia Capital Partners GP, LLC
3. Hestia Capital Management, LLC
4. Kurtis J. Wolf
EXHIBIT B
Form of Press Release
[Attached]
Pitney Bowes Announces Continued Refreshment of its Board of Directors
Chair Mary J. Guilfoile, Who Has Served With Distinction, to Step Down Following the 2024 Annual Meeting
William S. Simon and Jill Sutton, Who Collectively Possess Experience in Capital Allocation, Corporate Governance and Transformations, Have Been Added to the Board
STAMFORD, Conn., January 31, 2024 - Pitney Bowes Inc. (NYSE: PBI) (“Pitney Bowes” or the “Company”), a global shipping and mailing company that provides technology, logistics and financial services, today announced
that Mary J. Guilfoile will step down as Chair and retire from the Board of Directors (the “Board”) following the 2024 Annual Meeting of Stockholders (the “Annual Meeting”). The Board will elect a new Chair following Ms. Guilfoile’s retirement.
Additionally, the Company announced the addition of two highly qualified and independent members – William S. Simon and Jill Sutton – to its Board, effective February 1, 2024. Mr. Simon and Ms. Sutton were selected following a process that was
supported by an independent, nationally-recognized search firm.
The Company’s slate of director candidates for this year’s Annual Meeting is expected to include the following individuals:
Once the Company appoints its next permanent Chief Executive Officer, that individual is expected to be added to the Board and become its tenth member.
Ms. Guilfoile, Chair of the Board, commented:
“It has been a privilege to lead the Board of Pitney Bowes, a storied business with a more than 100-year history of change and innovation. The past year has been a particularly transformative one in terms of adding
several new directors, initiating a leadership transition and laying a foundation for enhanced value creation. I have enjoyed working with our interim Chief Executive Officer, Jason Dies, who has been establishing a results-driven culture and
taking decisive steps to position the organization for long-term success. I look forward to working with management and the rest of the Board, including our newest members, to build on this momentum between now and the Annual Meeting. I also want
to take this opportunity to thank the Company’s employees, customers, partners and investors for their confidence and trust during my time with Pitney Bowes.”
Ms. May, Chair of the Nominating and Governance Committee, added:
“On behalf of all my fellow directors, I want to thank Mary for her invaluable leadership during an important period for Pitney Bowes. She has overseen governance enhancements and strategic actions that we expect
will put the Company on stronger footing for years to come. Our entire Board also welcomes Bill and Jill, who collectively bring significant experience in areas such as capital allocation, corporate governance and transformations.”
In conjunction with today’s announcement, the Company has also entered into a cooperation agreement with Hestia Capital Management, LLC (collectively with its affiliates, “Hestia Capital”).
Mr. Wolf, a member of the Board and the Founder and Chief Investment Officer of Hestia Capital, concluded:
“I am pleased to have reached an agreement with Pitney Bowes to solidify Hestia Capital’s long-term support for the Company’s Board and strategic direction. I also want to thank Mary for her many contributions as
Chair. Looking ahead, I am confident that this Board will deliver meaningful value-enhancing results for shareholders, whom we represent, as well as for all of our other stakeholders.”
Additional information related to today’s announcements and the agreement with Hestia can be found on a Form 8-K filed with the U.S. Securities and Exchange Commission.
New Director Biographies
William S. Simon
Mr. Simon is an experienced public company director and former executive, with skills and perspectives that will be additive to Pitney Bowes’ Board. In addition to currently serving as a director of Darden
Restaurants, Inc. (NYSE: DRI) and Chairman of Hanesbrands Inc. (NYSE: HBI), Mr. Simon is an executive advisor to the KKR & Co. investment firm and President of WSS Venture Holdings, LLC, a consulting and investment company. From 2010 to 2014,
Mr. Simon served as President and CEO of Walmart U.S. (NYSE: WMT). Before that, he was Chief Operating Officer of Walmart U.S. He joined the company in 2006 as Executive Vice President of Professional Services and New Business Development. Prior to
Walmart, Mr. Simon held senior executive positions at Brinker International Inc. (NYSE: EAT), Diageo North America Inc. (NYSE: DEO) and Cadbury Schweppes plc. Mr. Simon was also Secretary of the Florida Department of Management Services and served
25 years in the U.S. Navy and Naval Reserves. He was previously a director of GameStop Corp. (NYSE: GME).
Jill Sutton
Ms. Sutton is a public company director and former executive with extensive experience that will be additive to Pitney Bowes’ Board. Ms. Sutton served as Chief Legal Officer, General Counsel and Corporate Secretary
at United Natural Foods, Inc. (NYSE: UNFI) for over three years, where she developed the company’s shareholder engagement program, was deeply involved in the Company’s ESG policies and programs, supported the realization of over $150 million in
synergies following UNFI’s acquisition of SuperValu, and helped to assure the Company’s supply chain remained operational through the COVID-19 crisis. Prior to UNFI, Ms. Sutton served in senior legal positions at General Motors Company (NYSE: GM),
Tim Hortons and The Wendy’s Company (Nasdaq: WEN). She also currently serves as a director of Miller Industries, Inc. (NYSE: MLR) and Potbelly Corp. (Nasdaq: PBPB). Ms. Sutton holds multiple degrees from The Ohio State University, including a J.D.
and a Master’s in Healthcare Administration.
About Pitney Bowes
Pitney Bowes (NYSE: PBI) is a global shipping and mailing company that provides technology, logistics and financial services to more than 90 percent of the Fortune 500. Small business, retail, enterprise and government clients around the world
rely on Pitney Bowes to reduce the complexity of sending mail and parcels. For the latest news, corporate announcements and financial results visit https://www.pitneybowes.com/us/newsroom.html. For additional information visit Pitney Bowes
at www.pitneybowes.com.
This document contains “forward-looking statements” about the Company’s expected or potential future business and financial performance. Forward-looking statements include, but are not limited to, statements about the
Company’s future progress, plans, market positioning and future events or conditions. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that could cause actual results to differ materially from
those projected. Factors which could cause future financial performance to differ materially from expectations include, without limitation, not realizing the anticipated benefits of our ongoing strategic initiatives, corporate cost optimization and
related restructuring efforts; declining physical mail volumes; changes in postal regulations or the operations and financial health of posts in the U.S. or other major markets or changes to the broader postal or shipping markets; our ability to
retain management and other employees; our ability to continue to grow and manage unexpected fluctuations in volumes, gain additional economies of scale and improve profitability within our Global Ecommerce segment; the loss of some of our larger
clients in our Global Ecommerce and Presort Services segments; the loss of, or significant changes to, United States Postal Service (USPS) commercial programs, or our contractual relationships with the USPS or their performance under those
contracts; the impacts on our cost of debt due to recent increases in interest rates and the potential for future interest rate hikes; and other factors as more fully outlined in the Company's 2022 Form 10-K Annual Report and other reports filed
with the Securities and Exchange Commission during 2023. Pitney Bowes assumes no obligation to update any forward-looking statements contained in this document as a result of new information, events or developments.
Contacts
For Media:
Kathleen Raymond
Head of Communications
203.351.7233
For Investors:
Phil Landler
VP, Investor Relations
203.351.6141
B-4